{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:54:33Z","timestamp":1790517273492,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"vor","delay-in-days":2312,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1074\/jbc.m114.558924","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T04:37:02Z","timestamp":1395808622000},"page":"13054-13065","source":"Crossref","is-referenced-by-count":142,"title":["Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine"],"prefix":"10.1016","volume":"289","author":[{"given":"Johan","family":"Vande Voorde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suna","family":"Sabuncuo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Noppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farahnaz","family":"Ranjbarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Fieuws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Balzarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Liekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M114.558924_bib1","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1021\/cr900028p","article-title":"Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer","volume":"109","author":"Parker","year":"2009","journal-title":"Chem. Rev"},{"key":"10.1074\/jbc.M114.558924_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(02)00788-X","article-title":"Nucleoside analogues and nucleobases in cancer treatment","volume":"3","author":"Galmarini","year":"2002","journal-title":"Lancet. Oncol"},{"key":"10.1074\/jbc.M114.558924_bib3","first-page":"6110","article-title":"Action of 2\u2032,2\u2032-difluorodeoxycytidine on DNA synthesis","volume":"51","author":"Huang","year":"1991","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M114.558924_bib4","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/0006-2952(94)90207-0","article-title":"Molecular effects of 2\u2032,2\u2032-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells","volume":"48","author":"Ross","year":"1994","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.M114.558924_bib5","first-page":"4024","article-title":"Comparison of the cellular pharmacokinetics and toxicity of 2\u2032,2\u2032-difluorodeoxycytidine and 1-\u03b2-d-arabinofuranosylcytosine","volume":"48","author":"Heinemann","year":"1988","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M114.558924_bib6","series-title":"Deoxynucleoside analogues in cancer therapy","first-page":"225","article-title":"Gemcitabine, mechanism of action and resistance","author":"Bergman","year":"2006"},{"key":"10.1074\/jbc.M114.558924_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0026-895X(25)09518-5","article-title":"Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2\u2032,2\u2032-difluorodeoxycytidine","volume":"38","author":"Heinemann","year":"1990","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M114.558924_bib8","first-page":"11","article-title":"Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism","volume":"22","author":"Heinemann","year":"1995","journal-title":"Semin. Oncol"},{"key":"10.1074\/jbc.M114.558924_bib9","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/0006-2952(92)90077-V","article-title":"Modulation of deoxycytidylate deaminase in intact human leukemia cells: action of 2\u2032,2\u2032-difluorodeoxycytidine","volume":"44","author":"Xu","year":"1992","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.M114.558924_bib10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"key":"10.1074\/jbc.M114.558924_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"Viaud","year":"2013","journal-title":"Science"},{"key":"10.1074\/jbc.M114.558924_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1479-5876-4-14","article-title":"Bacteria and cancer: cause, coincidence or cure? A review","volume":"4","author":"Mager","year":"2006","journal-title":"J. Transl. Med"},{"key":"10.1074\/jbc.M114.558924_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-9378-8-11","article-title":"Bacteria and tumours: causative agents or opportunistic inhabitants?","volume":"8","author":"Cummins","year":"2013","journal-title":"Infect. Agent. Cancer"},{"key":"10.1074\/jbc.M114.558924_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/gyno.1996.0316","article-title":"Prevalence of mycoplasma conserved DNA in malignant ovarian cancer detected using sensitive PCR-ELISA","volume":"63","author":"Chan","year":"1996","journal-title":"Gynecol. Oncol"},{"key":"10.1074\/jbc.M114.558924_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/gyno.1998.5177","article-title":"Assessment of archived paraffin-embedded cervical condyloma tissues for mycoplasma-conserved DNA using sensitive PCR-ELISA","volume":"71","author":"Kidder","year":"1998","journal-title":"Gynecol. Oncol"},{"key":"10.1074\/jbc.M114.558924_bib16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3748\/wjg.v7.i2.266","article-title":"Mycoplasma infections and different human carcinomas","volume":"7","author":"Huang","year":"2001","journal-title":"World J. Gastroenterol"},{"key":"10.1074\/jbc.M114.558924_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.lungcan.2004.01.007","article-title":"Does Mycoplasma sp. play role in small cell lung cancer?","volume":"45","author":"Pehlivan","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1074\/jbc.M114.558924_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.urology.2004.10.015","article-title":"Can mycoplasma-mediated oncogenesis be responsible for formation of conventional renal cell carcinoma?","volume":"65","author":"Pehlivan","year":"2005","journal-title":"Urology"},{"key":"10.1074\/jbc.M114.558924_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-230X-10-132","article-title":"Mycoplasma hyorhinis infection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells","volume":"10","author":"Yang","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1074\/jbc.M114.558924_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1749-8090-6-137","article-title":"Bacterial and fungal microflora in surgically removed lung cancer samples","volume":"6","author":"Apostolou","year":"2011","journal-title":"J. Cardiothorac. Surg"},{"key":"10.1074\/jbc.M114.558924_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1471-2407-11-233","article-title":"Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer","volume":"11","author":"Urbanek","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1074\/jbc.M114.558924_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.18632\/oncotarget.256","article-title":"Association of Mycoplasma hominis infection with prostate cancer","volume":"2","author":"Barykova","year":"2011","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.M114.558924_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11255-012-0299-5","article-title":"Can mycoplasma contribute to formation of prostate cancer?","volume":"45","author":"Erturhan","year":"2013","journal-title":"Int. Urol. Nephrol"},{"key":"10.1074\/jbc.M114.558924_bib24","doi-asserted-by":"crossref","first-page":"23196","DOI":"10.1074\/jbc.M112.351940","article-title":"Inhibition of mycobacterial infection by the tumor suppressor PTEN","volume":"287","author":"Huang","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.558924_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","article-title":"Mycoplasma pneumoniae and its role as a human pathogen","volume":"17","author":"Waites","year":"2004","journal-title":"Clin. Microbiol. Rev"},{"key":"10.1074\/jbc.M114.558924_bib26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1128\/MMBR.62.4.1094-1156.1998","article-title":"Molecular biology and pathogenicity of mycoplasmas","volume":"62","author":"Razin","year":"1998","journal-title":"Microbiol. Mol. Biol. Rev"},{"key":"10.1074\/jbc.M114.558924_bib27","series-title":"Mycoplasmas, molecular biology and pathogenesis","first-page":"417","article-title":"Mycoplasmas which infect humans","author":"Krause","year":"1992"},{"key":"10.1074\/jbc.M114.558924_bib28","series-title":"Mycoplasmas, molecular biology and pathogenesis","first-page":"211","article-title":"Sources of nucleotides","author":"Finch","year":"1992"},{"key":"10.1074\/jbc.M114.558924_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/10408419709115140","article-title":"The comparative metabolism of the mollicutes (mycoplasmas): the utility for taxonomic classification and the relationship of putative gene annotation and phylogeny to enzymatic function in the smallest free-living cells","volume":"23","author":"Pollack","year":"1997","journal-title":"Crit. Rev. Microbiol"},{"key":"10.1074\/jbc.M114.558924_bib30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1128\/jb.158.3.943-947.1984","article-title":"Uptake and utilization of deoxynucleoside 5\u2032-monophosphates by Mycoplasma mycoides subsp. mycoides","volume":"158","author":"Neale","year":"1984","journal-title":"J. Bacteriol"},{"key":"10.1074\/jbc.M114.558924_bib31","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1128\/jb.175.16.5281-5285.1993","article-title":"Identification of Mycoplasma pirum genes involved in the salvage pathways for nucleosides","volume":"175","author":"Tham","year":"1993","journal-title":"J. Bacteriol"},{"key":"10.1074\/jbc.M114.558924_bib32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bcp.2008.04.019","article-title":"The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: implications for cancer therapy","volume":"76","author":"Bronckaers","year":"2008","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.M114.558924_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BJ20112225","article-title":"Characterization of pyrimidine nucleoside phosphorylase of Mycoplasma hyorhinis: implications for the clinical efficacy of nucleoside analogues","volume":"445","author":"Vande Voorde","year":"2012","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M114.558924_bib34","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1470-2045(09)70037-3","article-title":"Improvement of purine and pyrimidine antimetabolite-based anticancer treatment by selective suppression of mycoplasma-encoded catabolic enzymes","volume":"10","author":"Liekens","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1074\/jbc.M114.558924_bib35","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0006-2952(00)00253-7","article-title":"Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2\u2032-deoxyribonucleosides","volume":"59","author":"Fukushima","year":"2000","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.M114.558924_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1620\/tjem.88.69","article-title":"Establishment of cell lines in vitro from a mammary ascites tumor of mouse and biological properties of the established lines in a serum containing medium","volume":"88","author":"Nakano","year":"1966","journal-title":"Tohoku J. Exp. Med"},{"key":"10.1074\/jbc.M114.558924_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF01538800","article-title":"Single-step selection of mouse FM3A cell mutants defective in thymidylate synthetase","volume":"6","author":"Ayusawa","year":"1980","journal-title":"Somatic Cell Genet"},{"key":"10.1074\/jbc.M114.558924_bib38","doi-asserted-by":"crossref","DOI":"10.1080\/15257770.2013.853783","article-title":"Mycoplasma pneumoniae thymidine phosphorylase","author":"Wang","year":"2014","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1074\/jbc.M114.558924_bib39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0167-4838(84)90231-0","article-title":"Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells","volume":"785","author":"Balzarini","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M114.558924_bib40","first-page":"1340","article-title":"Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine","volume":"24","author":"Neff","year":"1996","journal-title":"Exp. Hematol"},{"key":"10.1074\/jbc.M114.558924_bib41","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1124\/dmd.110.034397","article-title":"Influence of cytidine deaminase on antitumor activity of 2\u2032-deoxycytidine analogs in vitro and in vivo","volume":"38","author":"Yoshida","year":"2010","journal-title":"Drug Metab. Dispos"},{"key":"10.1074\/jbc.M114.558924_bib42","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/sj.leu.2403977","article-title":"Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells","volume":"19","author":"Bardenheuer","year":"2005","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M114.558924_bib43","doi-asserted-by":"crossref","first-page":"e27231","DOI":"10.4161\/onci.27231","article-title":"Macrophages increase the resistance of pancreatic adenocarcinoma cells to gemcitabine by up-regulating cytidine deaminase","volume":"2","author":"Amit","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1074\/jbc.M114.558924_bib44","article-title":"Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by up-regulating cytidine deaminase","author":"Weizman","year":"2013","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M114.558924_bib45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1099\/00207713-38-4-417","article-title":"Purine and pyrimidine metabolism in Mollicutes species","volume":"38","author":"McElwain","year":"1988","journal-title":"Int. J. Syst. Bacteriol"},{"key":"10.1074\/jbc.M114.558924_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/genomeA.00101-12","article-title":"Complete genome sequence of Mycoplasma hyorhinis strain SK76","volume":"1","author":"Goodison","year":"2013","journal-title":"Genome Announc"},{"key":"10.1074\/jbc.M114.558924_bib47","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/bjc.1995.392","article-title":"Increased sensitivity to the prodrug 5\u2032-deoxy-5-fluorouridine and modulation of 5-fluoro-2\u2032-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase","volume":"72","author":"Patterson","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1074\/jbc.M114.558924_bib48","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann. Oncol"},{"key":"10.1074\/jbc.M114.558924_bib49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0022-1759(84)90473-3","article-title":"Mycoplasma contamination: a hazard of screening hybridoma supernatants for inhibition of [3H]thymidine incorporation","volume":"67","author":"Jakway","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1074\/jbc.M114.558924_bib50","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/eji.1830150710","article-title":"Inhibition of [3H]thymidine incorporation by Mycoplasma arginini-infected cells due to enzymatic cleavage of the nucleoside","volume":"15","author":"Sinigaglia","year":"1985","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/jbc.M114.558924_bib51","first-page":"125","article-title":"Rate of incorporation of radiolabelled nucleosides does not necessarily reflect the metabolic state of cells in culture: effects of latent mycoplasma contamination","volume":"63","author":"Merkenschlager","year":"1988","journal-title":"Immunology"},{"key":"10.1074\/jbc.M114.558924_bib52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/hyb.1989.8.249","article-title":"Elimination of mycoplasmas from mouse myeloma cells by intraperitoneal passage in mice and by antibiotic treatment","volume":"8","author":"Hirschberg","year":"1989","journal-title":"Hybridoma"},{"key":"10.1074\/jbc.M114.558924_bib53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1438-4221(00)80130-7","article-title":"Decontamination of a mycoplasma-infected Chlamydia pneumoniae strain by pulmonary passage in SCID mice","volume":"290","author":"Essig","year":"2000","journal-title":"Int. J. Med. Microbiol"},{"key":"10.1074\/jbc.M114.558924_bib54","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1124\/mol.113.088625","article-title":"Mycoplasma hyorhinis-encoded purine nucleoside phosphorylase: kinetic properties and its effect on the cytostatic potential of purine-based anticancer drugs","volume":"84","author":"Vande Voorde","year":"2013","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M114.558924_bib55","first-page":"991","article-title":"Therapy of refractory\/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase): a pilot study","volume":"5","author":"Kreis","year":"1991","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M114.558924_bib56","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S1470-2045(12)70345-5","article-title":"TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial","volume":"13","author":"Yoshino","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820387913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820387913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M114.558924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:48:08Z","timestamp":1746161288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820387913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":56,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0021925820387913"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m114.558924","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}